The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance.
暂无分享,去创建一个
[1] M. Griswold,et al. Suppression of spermatogenesis by bisdichloroacetyldiamines is mediated by inhibition of testicular retinoic acid biosynthesis. , 2011, Journal of andrology.
[2] Patrick W. Lee,et al. Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of Metastasis , 2011, Stem cells.
[3] L. Nicholson,et al. Finding cancer stem cells: are aldehyde dehydrogenases fit for purpose? , 2010, The Journal of pathology.
[4] K. Barth,et al. Disulfiram: an old therapeutic with new applications. , 2010, CNS & neurological disorders drug targets.
[5] S. Choe,et al. Maternal and Zygotic aldh1a2 Activity Is Required for Pancreas Development in Zebrafish , 2009, PloS one.
[6] D. Overstreet,et al. A selective ALDH-2 inhibitor reduces anxiety in rats , 2009, Pharmacology Biochemistry and Behavior.
[7] A. Bairoch,et al. Human aldehyde dehydrogenase genes: alternatively spliced transcriptional variants and their suggested nomenclature , 2009, Pharmacogenetics and genomics.
[8] S. Yin,et al. Substrate specificity of human and yeast aldehyde dehydrogenases. , 2009, Chemico-biological interactions.
[9] Gregg Duester,et al. Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems. , 2009, Blood.
[10] J. Moreb. Aldehyde dehydrogenase as a marker for stem cells. , 2008, Current stem cell research & therapy.
[11] H. Baker,et al. ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells , 2008, Molecular Cancer.
[12] C. Brocker,et al. Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily , 2008, Expert opinion on drug metabolism & toxicology.
[13] Henry V. Baker,et al. ALDH isozymes downregulation effects on cell growth and gene expression in lung cancer cell lines , 2007 .
[14] J. Moreb,et al. Heterogeneity of aldehyde dehydrogenase expression in lung cancer cell lines is revealed by Aldefluor flow cytometry‐based assay , 2007, Cytometry. Part B, Clinical cytometry.
[15] J. Moreb,et al. RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide , 2006, Cancer Chemotherapy and Pharmacology.
[16] Y. Koutalos,et al. Human Aldehyde Dehydrogenase 3A1 Inhibits Proliferation and Promotes Survival of Human Corneal Epithelial Cells* , 2005, Journal of Biological Chemistry.
[17] D. Niedzwiecki,et al. Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34. , 2005, Blood.
[18] Vasilis Vasiliou,et al. Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family , 2005, Human Genomics.
[19] T. Lister,et al. Characterization of Cells with a High Aldehyde Dehydrogenase Activity from Cord Blood and Acute Myeloid Leukemia Samples , 2005, Stem cells.
[20] N. Kröger,et al. Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants , 2005, Bone Marrow Transplantation.
[21] D. Mohuczy,et al. Retinoic Acid Down-Regulates Aldehyde Dehydrogenase and Increases Cytotoxicity of 4-Hydroperoxycyclophosphamide and Acetaldehyde , 2005, Journal of Pharmacology and Experimental Therapeutics.
[22] M. Stojkovic,et al. Phenotypic Characterization of Murine Primitive Hematopoietic Progenitor Cells Isolated on Basis of Aldehyde Dehydrogenase Activity , 2004, Stem cells.
[23] J. Nolta,et al. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. , 2004, Blood.
[24] V. Vasiliou,et al. Role of Human Aldehyde Dehydrogenases in Endobiotic and Xenobiotic Metabolism , 2004, Drug metabolism reviews.
[25] P. Chambon,et al. A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[26] V. Vasiliou,et al. Aldehyde dehydrogenase gene superfamily: the 2002 update. , 2003, Chemico-biological interactions.
[27] U. Reichert,et al. The effect of a novel irreversible inhibitor of aldehyde dehydrogenases 1 and 3 on tumour cell growth and death. , 2001, Chemico-biological interactions.
[28] N. Sládek,et al. Inhibition of ALDH3A1-catalyzed oxidation by chlorpropamide analogues. , 2001, Chemico-biological interactions.
[29] V. Vasiliou,et al. Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism. , 2000, Chemico-biological interactions.
[30] V. Vasiliou,et al. Polymorphisms of Human Aldehyde Dehydrogenases , 2000, Pharmacology.
[31] M. Schweder,et al. Expression of antisense RNA to aldehyde dehydrogenase class-1 sensitizes tumor cells to 4-hydroperoxycyclophosphamide in vitro. , 2000, The Journal of pharmacology and experimental therapeutics.
[32] O. Colvin,et al. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[33] N. Sládek. Aldehyde dehydrogenase-mediated cellular relative insensitivity to the oxazaphosphorines. , 1999, Current pharmaceutical design.
[34] A. Bairoch,et al. Eukaryotic aldehyde dehydrogenase (ALDH) genes: human polymorphisms, and recommended nomenclature based on divergent evolution and chromosomal mapping. , 1999, Pharmacogenetics.
[35] P. Chambon,et al. Embryonic retinoic acid synthesis is essential for early mouse post-implantation development , 1999, Nature Genetics.
[36] A Yoshida,et al. Human aldehyde dehydrogenase gene family. , 1998, European journal of biochemistry.
[37] U. Dräger,et al. Restricted expression and retinoic acid-induced downregulation of the retinaldehyde dehydrogenase type 2 (RALDH-2) gene during mouse development , 1997, Mechanisms of Development.
[38] A. Townsend,et al. Protection by transfected rat or human class 3 aldehyde dehydrogenase against the cytotoxic effects of oxazaphosphorine alkylating agents in hamster V79 cell lines. Demonstration of aldophosphamide metabolism by the human cytosolic class 3 isozyme. , 1996, The Journal of biological chemistry.
[39] A. Klyosov. Kinetics and specificity of human liver aldehyde dehydrogenases toward aliphatic, aromatic, and fused polycyclic aldehydes. , 1996, Biochemistry.
[40] Richard J. Jones,et al. Assessment of aldehyde dehydrogenase in viable cells. , 1995, Blood.
[41] V. Vasiliou,et al. Role of the Ah Receptor and the Dioxin‐Inducible [Ah] Gene Battery in Toxicity, Cancer, and Signal Transduction a , 1993, Annals of the New York Academy of Sciences.
[42] B. Johansson. A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites , 1992, Acta psychiatrica Scandinavica. Supplementum.
[43] J. Russo,et al. Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant L1210 cells. , 1988, Cancer research.
[44] N. Sládek. Human aldehyde dehydrogenases: Potential pathological, pharmacological, and toxicological impact , 2003, Journal of biochemical and molecular toxicology.
[45] V. Vasiliou,et al. Aldehyde Dehydrogenase Gene Superfamily , 1999 .
[46] R. Lindahl,et al. Aldehyde dehydrogenases and their role in carcinogenesis. , 1992, Critical reviews in biochemistry and molecular biology.
[47] D. Agarwal,et al. Pharmacogenetics of aldehyde dehydrogenase (ALDH). , 1990, Pharmacology & therapeutics.
[48] P. A. Maki,et al. Xenobiotic oxidation catalyzed by aldehyde dehydrogenases. , 1989, Drug metabolism reviews.
[49] Agarwal Dp,et al. Human aldehyde dehydrogenase isozymes and alcohol sensitivity. , 1987 .
[50] R. Pietruszko. Aldehyde dehydrogenase isozymes. , 1983, Isozymes.
[51] G. S. Whitt,et al. Isozymes : current topics in biological and medical research , 1977 .